Order Article Reprints

Mayer S, Prechtl M, Liebfried P, Cadeddu R-P, Stuhldreier F, Kohl M, Wenzel F, Stork B, Wesselborg S, Proksch P, et al. First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy. Marine Drugs. 2019; 17(9):521. https://doi.org/10.3390/md17090521

Mayer, Saskia, Marie Prechtl, Pia Liebfried, Ron-Patrick Cadeddu, Fabian Stuhldreier, Matthias Kohl, Folker Wenzel, Björn Stork, Sebastian Wesselborg, Peter Proksch, and et al. 2019. "First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy" Marine Drugs 17, no. 9: 521. https://doi.org/10.3390/md17090521

Mayer, S., Prechtl, M., Liebfried, P., Cadeddu, R.-P., Stuhldreier, F., Kohl, M., Wenzel, F., Stork, B., Wesselborg, S., Proksch, P., Germing, U., Haas, R., & Jäger, P. (2019). First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2′,4′-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2′,4′-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer Therapy. Marine Drugs, 17(9), 521. https://doi.org/10.3390/md17090521